2021
DOI: 10.22541/au.162145883.36815443/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Response of Astrocytes to Blood Exposure due to Shunt Insertion in vitro

Abstract: The breakdown of the ventricular zone (VZ) with the presence of blood in cerebrospinal fluid (CSF) has been shown to increase shunt catheter obstruction in the treatment of hydrocephalus, but the mechanisms by which this occurs are generally unknown. Using a custom-built incubation chamber, we immunofluorescently assayed cell attachment and morphology on shunt catheters with and without blood after 14 days. Samples exposed to blood showed significantly increased cell attachment (average total cell count 392.0±… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 29 publications
(48 reference statements)
1
0
0
Order By: Relevance
“…Targeted therapies that inhibit astrocyte cell activation were able to significantly reduce astrocyte cell adhesion on PDMS coated surfaces mimicking the shunt surface. These results are in accordance with other studies indicating that the knockout of reactive astrocyte activating factors slows disease progression [ 33 ], dampening the formation of reactive astrocytes prevents neuronal death [ 36 ], and astrogliosis inhibition attenuates hydrocephalus [ 40 , 41 ]. TGF-ß suppresses A1 astrocyte activation [ 8 ], reverses the formation of A1 astrocytes by fibroblast growth factor (FGF) signaling [ 42 ], and greatly reduces the expression of A1-specific markers [ 43 ].…”
Section: Discussionsupporting
confidence: 92%
“…Targeted therapies that inhibit astrocyte cell activation were able to significantly reduce astrocyte cell adhesion on PDMS coated surfaces mimicking the shunt surface. These results are in accordance with other studies indicating that the knockout of reactive astrocyte activating factors slows disease progression [ 33 ], dampening the formation of reactive astrocytes prevents neuronal death [ 36 ], and astrogliosis inhibition attenuates hydrocephalus [ 40 , 41 ]. TGF-ß suppresses A1 astrocyte activation [ 8 ], reverses the formation of A1 astrocytes by fibroblast growth factor (FGF) signaling [ 42 ], and greatly reduces the expression of A1-specific markers [ 43 ].…”
Section: Discussionsupporting
confidence: 92%